Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,409
Award facts
- Contract value 100% obligated
- $15,409.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,409.22 to supply Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive, non-set-aside delivery order was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, utilizing firm fixed pricing. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valid through December 2026 that enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio of delivery orders through the DLA covering multiple therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's demonstrated capability to compete successfully for federal contracts and manage large-scale pharmaceutical supply chains has established it as a key vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Ozempic represents a routine pharmaceutical supply transaction within the company's broader relationship with DLA to support military medical needs.
Quick answers
Who was awarded contract SPE2DR26F9BCL?
SPE2DR26F9BCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F9BCL worth?
The government has obligated $15,409 on SPE2DR26F9BCL.
Is contract SPE2DR26F9BCL an order under another contract?
Yes. SPE2DR26F9BCL is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BCL competed?
The extent of competition for SPE2DR26F9BCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award